Washington: A drug that was initially used to treat insulin resistance in diabetics has shown promise as a way to improve cognitive function in Alzheimer’s sufferers.Working with genetically engineered mice designed to serve as models for Alzheimer’s, University of Texas Medical Branch at Galveston researchers found that treatment with the anti-insulin-resistance drug rosiglitazone enhanced learning and memory as well as normalized insulin resistance.The scientists believe that the drug produced the response by reducing the negative influence of Alzheimer’s on the behavior of a key brain-signaling molecule.The molecule, called extracellular signal-regulated kinase (ERK), becomes hyperactive both in the brains of Alzheimer’s patients and in the mice at a disease stage corresponding to mild cognitive impairment in human Alzheimer’s. This excessive activity leads to improper synaptic transmission between neurons, interfering with learning and memory."Using this drug appears to restore the neuronal signaling required for proper cognitive function," said UTMB professor Larry Denner, the lead author of the study.
Modi says people of UP can bring `Ram Rajya`
Audience verdict on ‘Dhoom 3’
Five cops held for raping minor in Chandigarh
Lieutenant Governor Najeeb Jung recommends President`s rule in Delhi